Rapid induction of myeloid leukemia by co-expressing BCR-ABL and AML1/MDS1/EVI1 fusion genes.

被引：0
作者：
Cuenco, GM [1 ]
Joyce, J [1 ]
Ren, RB [1 ]
机构：
[1] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1975
引用
收藏
页码：459A / 459A
页数：1
相关论文
共 50 条
  • [21] The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSFIR promoter, but only AML1/MDS1 has tumor-promoter properties
    Zent, C. S.
    Mathieu, C.
    Claxton, D. F.
    Zhang, D.-E.
    Proceedings of the National Academy of Sciences of the United States of America, 93 (03):
  • [22] The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells
    Vitalyi Senyuk
    Soumen Chakraborty
    Fady M Mikhail
    Rui Zhao
    Yiqing Chi
    Giuseppina Nucifora
    Oncogene, 2002, 21 : 3232 - 3240
  • [23] EVI1 and MDS1/EVI1 Expression During Primary Human Hematopoietic Progenitor Cell Differentiation into Various Myeloid Lineages
    Steinleitner, Katarina
    Rampetsreiter, Paulina
    Koeffel, Rene
    Ramanathan, Gajalakshmi
    Mannhalter, Christine
    Strobl, Herbert
    Wieser, Rotraud
    ANTICANCER RESEARCH, 2012, 32 (11) : 4883 - 4889
  • [24] Frequency of TEL/AML1 and BCR/ABL fusion genes in children with acute lymphoblastic leukemia
    Artigas A, Carmen Gloria
    Cabrera C, Maria Elena
    Melo A, Angelica
    Paez F, Eduardo
    Arriagada M, Monica
    Astete A, Carmen
    Roa E, Ivdn
    Roa S, Juan Carlos
    REVISTA MEDICA DE CHILE, 2006, 134 (11) : 1367 - 1376
  • [25] Normal intergenic splicing of MDS1 and EVI1, two proto-oncogenes associated with myeloid leukemia
    Fears, S
    Mathieu, C
    ZeleznikLe, N
    Rowley, JD
    Nucifora, G
    BLOOD, 1995, 86 (10) : 134 - 134
  • [26] Human AML1/MDS1/EVI1 t(3;21)(q26;q22) fusion gene induces acute myelogenous leukemia in mice.
    Cuenco, GM
    Ren, R
    BLOOD, 1999, 94 (10) : 277A - 277A
  • [27] The chimeric genes AML1/MDS1 and AML1/EAP inhibit AML1B activation at the CSF1R promoter, but only AML1/MDS1 has tumor-promoter properties
    Zent, CS
    Mathieu, C
    Claxton, DF
    Zhang, DE
    Tenen, DG
    Rowley, JD
    Nucifora, G
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (03) : 1044 - 1048
  • [28] Acute myeloid leukemia with t(3;21)(q26.2;q22) developing following low-dose methotrexate therapy for rheumatoid arthritis and expressing two AML1/MDS1/EVI1 fusion proteins: A case report
    Tanaka, Keisuke
    Oshikawa, Gaku
    Akiyama, Hiroki
    Ishida, Shinya
    Nagao, Toshikage
    Yamamoto, Masahide
    Miura, Osamu
    ONCOLOGY LETTERS, 2017, 14 (01) : 97 - 102
  • [29] Oligomerization of the leukemia-associated protein AML1/MDS1/EVI1 and its interaction with CtBP and, HDAC1 are necessary for upregulation of the cell cycle and abnormal hematopoetic differentiation.
    Senyuk, V
    Chakraborty, S
    Mikhail, F
    Sitailo, S
    Nucifora, G
    BLOOD, 2001, 98 (11) : 834A - 834A
  • [30] The leukemia-associated gene MDS1/EVI1 is a new type of GATA-binding transactivator
    J Soderholm
    H Kobayashi
    C Mathieu
    JD Rowley
    G Nucifora
    Leukemia, 1997, 11 : 352 - 358
12345